Roche Paying $390m Up Front For Fibrosis-Fighting Promedior

SC1911_Aquisition_377287183_1200.jpg
Roche will pay $390m initially and up to $1bn in milestone fees. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business